Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Other material
confidence 75%
filed 2026-06-05
Item 3.03
The company effected a 1-for-20 reverse stock split on June 5, 2026, which was authorized by stockholders on April 29, 2026. This capital restructuring consolidates shares and adjusts exercise prices and share reserves, materially modifying the rights and economic interests of all security holders.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 8.01
Edesa Biotech disclosed favorable exploratory clinical data for paridiprubart showing a 32% relative reduction in 28-day mortality in AKI patients and a 23% relative reduction in MAKE30 incidence, presented at the ERA Congress. While this represents material clinical progress for a biotech company's lead candidate, the disclosure emphasizes these are exploratory, post-hoc analyses not prespecified in the statistical plan, with nominal p-values not adjusted for multiplicity and explicit caution that confirmatory studies would be required. This clinical milestone does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, restatement, or litigation), making it best classified as other_material given its potential significance to investors assessing the company's pipeline prospects.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
A Special Committee is conducting an ongoing strategic review evaluating financing, recapitalization, restructuring, M&A, and other strategic transactions, with engagement of major financial advisors (Houlihan Lokey and FTI Consulting) and active discussions with lenders regarding potential credit agreement amendments.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 8.01
This disclosure announces translational pharmacometric modeling and initial Phase 1 safety data for CLYM116, an anti-APRIL monoclonal antibody candidate. The announcement includes positive preliminary safety findings (no serious adverse events, dose-limiting toxicities, or discontinuations in 49 healthy volunteers up to 320 mg) and supportive pharmacokinetic/pharmacodynamic modeling suggesting potential for less-frequent dosing. While this is a clinical development milestone for a pipeline asset, it does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or litigation). The disclosure would be material to investors evaluating the company's pipeline progress and risk profile, particularly given the positive safety profile and advancement toward Phase 2 dosing in IgAN patients expected in Q3 2026.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 8.01
The Board authorized an additional $370.0 million share repurchase authorization on June 3, 2026, bringing the aggregate authorization to $2.6 billion, signaling management's confidence in the stock's valuation and the company's financial position.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
Dominion Energy entered into an underwriting agreement on June 3, 2026 for the sale of $825 million in senior notes due 2036. While this is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, it does not fit cleanly into the more specific event categories (it is not a dilutive equity issuance, M&A activity, or a financial covenant breach). The disclosure is material as it represents a significant financing transaction, but the taxonomy lacks a dedicated "debt issuance" category.
View raw filing on EDGAR →
8-K
Other material
confidence 55%
filed 2026-06-05
Item 1.01
Goldman Sachs Real Estate Finance Trust renewed its advisory agreement with Goldman Sachs Asset Management, L.P. for an additional one-year period effective June 10, 2026, continuing the existing advisory relationship with no substantive changes to terms.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
The company disclosed routine monthly distributions to shareholders and two significant loan originations totaling $186 million in new mortgage lending activity: a $53.0 million Durham Multifamily loan and a $133.0 million Chicago Multifamily loan, representing material operational activity for the real estate finance trust.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 8.01
Fortress Net Lease REIT declared distributions on May 29, 2026, with varying net distributions per share across six share classes ranging from $0.0547 to $0.0729 gross, affecting shareholder returns.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
Universal Insurance Holdings amended its 5.625% Senior Unsecured Notes indenture on June 3, 2026, with majority noteholder consent. The amendments shorten the redemption notice period from 30 days to 5 days and permit conditional redemption notices, providing "greater operational flexibility" for redemption. While this is a material debt modification affecting the Company's $XXX million in outstanding notes, it does not fit cleanly into the covenant_breach or dilutive_issuance categories—it is a negotiated amendment to existing debt terms, not a breach or new issuance. The materiality stems from the modification of significant debt obligations and the Company's apparent intent to exercise redemption flexibility.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
Falcon's Attractions (a subsidiary) entered into a Master Consulting Services Agreement valued at approximately $10.6 million to provide master plan design consulting services for a theme park in Arizona. While this is a material contract for a design consulting company, it does not fit neatly into the standard 8-K event taxonomy (not M&A, not an earnings release, not an executive change, etc.). The materiality threshold and revenue significance warrant disclosure, but the event is best classified as other_material given the absence of a more specific category.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 3.03
Alphabet filed Certificates of Designations establishing Series A and Series B Preferred Stock with material rights modifications, including dividend restrictions on junior stock, mandatory conversion features with price-based conversion rates, and liquidation preferences that establish new senior securities with preferential rights.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
Santander Holdings USA completed a public offering of $2.5 billion in aggregate principal amount of senior notes across three tranches (2030, 2032, and 2037 maturities). While this is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, it does not fit cleanly into the more specific event categories (ma_activity applies to acquisitions/dispositions/mergers, not routine debt offerings; dilutive_issuance applies to equity securities, not debt). The disclosure is material but represents a financing event outside the standard taxonomy.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 2.03
MSD Investment Corp. entered into Amendment No. 1 to its Senior Secured Credit Agreement, increasing the limitation on Shorter Term Unsecured Indebtedness from $200 million to $600 million, thereby expanding its borrowing capacity under the facility.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
The disclosure announces a postponement of an extraordinary general meeting (EGM) from June 9 to June 12, 2026, to seek shareholder approval for extending the Company's initial business combination deadline from June 12, 2026 to June 12, 2027. While this involves a shareholder vote, the core event is the extension of the business combination deadline itself—a material corporate action for a SPAC that affects the timeline for completing its fundamental purpose. This does not fit cleanly into shareholder_vote_results (which typically reports vote outcomes, not the scheduling of future votes) nor into other specific categories, making other_material the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-05
Item 2.03
The filing discloses creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, though the substantive details of the obligation are not fully provided in the available excerpts.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
Shareholders redeemed 7,167,225 Ordinary Shares at approximately $10.66 per share ($76.4 million aggregate), reducing outstanding shares from approximately 15.9 million to 8.75 million and leaving $46.2 million in the Trust Account, materially affecting the Company's capital structure and cash position.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
The Sponsor distributed 2,781,776 Class B shares to its constituent members, including 478,010 shares each to CEO Paul Grinberg, CFO Douglas Horlick, and Director Jaime Vieser, representing a material change in share ownership and executive equity interests.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 5.03
Long Table Growth Corp. adopted an Amended and Restated Memorandum and Articles of Association effective June 3, 2026, in connection with the Company's IPO.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 7.01
BioCardia disclosed receipt of FDA meeting minutes confirming that its ongoing CardiAMP Heart Failure II Trial may support Premarket Approval (PMA) for the CardiAMP Cell Therapy System. This is a material regulatory milestone for a clinical-stage biotech company, as FDA confirmation of trial adequacy for PMA is a significant de-risking event that would affect investor assessment of the company's path to commercialization. However, this does not fit neatly into the standard taxonomy categories (not an earnings release, executive change, M&A, impairment, or other enumerated events), warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 7.01
The disclosure announces results from an independent market landscape assessment for Annamycin in R/R AML, a clinical-stage asset. While this is material information about a key product candidate's competitive positioning, it does not fit cleanly into the standard taxonomy categories (not earnings, M&A, litigation, impairment, or other defined events). The assessment results could influence investor perception of the drug's commercial viability, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 8.01
The filing discloses the Trust's first cash distribution of $351,669.96 from staking rewards and announces an ongoing monthly (or quarterly minimum) distribution policy. While this is a routine operational disclosure for an ETF, the announcement of the inaugural distribution and the establishment of a regular distribution schedule would be material to investors evaluating the Trust's income-generating characteristics and cash flow to shareholders. This does not fit neatly into earnings_release (which typically applies to operating company financial results) but represents a material distribution event specific to the Trust's staking operations.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 1.01
The disclosure describes entry into a "Remunerated Private Investment Agreement" involving a $1,000,000 capital deployment by Nomadar to Make A Mark Events SRL (owned by a company investor) with a 2.7% monthly return and 30-day repayment terms. While Item 1.01 typically covers M&A activity, this transaction appears to be a related-party investment or financing arrangement rather than a traditional acquisition or material disposition. The structure—a short-term, interest-bearing loan to an affiliate—does not fit cleanly into the M&A taxonomy but is material due to the significant capital commitment and related-party nature.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
The filing discloses preliminary assets under management (AUM) as of May 31, 2026, via press release. For an asset management company like Artisan Partners, AUM is a key operational metric that investors monitor closely to assess business performance and growth trends. While this is not a formal earnings release, the disclosure of material AUM figures would affect a reasonable investor's assessment of the company's business trajectory and is material to the total mix of information available.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 1.01
Madison Air Solutions entered into a Seventh Amendment to its Credit Agreement on June 4, 2026, reducing the interest rate on its incremental term loan facility by 100 basis points from Term SOFR plus 2.75% to Term SOFR plus 1.75%, materially improving the registrant's financing costs.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 3.03
Strive, Inc. disclosed material modifications to the rights of security holders through Certificates of Amendment to the Certificate of Designation for Variable Rate Series A Perpetual Preferred Stock (SATA Stock), increasing authorized shares to 40,000,000, which affects shareholder voting power and dilution risk.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 5.02
Mag Magna Corp established an Executive Committee (composed of Harpreet Sangha and Jamal Khurshid) and an Audit Committee (composed of Gonca Demir, Daniel Marcus, and Nicholas Gregory), and adopted their respective charters, reflecting material governance and board oversight structural changes.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 3.03
The Board authorized redemption of all preferred share purchase rights under the Shareholder Rights Agreement (poison pill) effective June 5, 2026, with rights holders receiving $0.001 per right and the agreement terminating. This eliminates the company's takeover defenses and materially modifies security holder rights, affecting investor assessment of acquisition risk and control dynamics.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 7.01
The filing discloses a material corporate name change from Skillz Inc. to Firy Inc. with an associated ticker symbol change from SKLZ to FIRY, effective June 18-22, 2026. While this is a significant corporate action that would affect investor identification and trading of the security, it does not fit neatly into the more specific event categories (it is not an M&A activity, executive change, financial restatement, or other defined material event). The accompanying reorganized business segment information suggests a broader strategic repositioning. This is classified as other_material because it represents a material corporate identity change that does not match the taxonomy's more specific event types.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 8.01
The Trust announced a cash distribution of $0.091522 per trust certificate payable to certificateholders, which is material to investors as it directly affects the economic return on their investment.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 1.01
The Company entered into multiple material definitive agreements on June 4, 2026, including amendments to its Operating Partnership Agreement, Dealer Manager Agreement, and Advisory Agreement, to reflect the designation of new Class L-S and Class L-I share classes with distinct repurchase limitations. The company also adopted a Fourth Amended and Restated Declaration of Trust designating these new share classes, representing a material capital structure change affecting investor rights and the company's operational framework.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-04
Item 1.01
Marsh & McLennan Companies entered into a new $4.25 billion five-year revolving credit facility with Citibank as administrative agent, effective June 2, 2026, and simultaneously terminated its prior $3.5 billion multi-currency revolving credit facility. This refinancing transaction materially affects the company's liquidity and capital structure.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-04
Item 8.01
Patterson-UTI Energy completed a debt refinancing, redeeming $482.5 million of 3.95% Senior Notes due 2028 using proceeds from a new $500 million 6.050% Senior Notes offering, materially affecting the company's capital structure and interest expense profile.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-04
Item 1.01
Highwoods Realty modified its $150 million unsecured term loan, extending the maturity date from May 2027 to June 2029 and revising interest rate terms to SOFR plus 90 basis points, with an optional two-year extension available. The amendment includes sustainability-linked pricing adjustments and materially affects the company's liquidity profile and debt service obligations.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 8.01
PPL Electric announced PUC approval of a settlement agreement permitting a $275 million annual base distribution revenue increase effective July 1, 2026. This is a material regulatory approval affecting the subsidiary's revenue and financial position, but does not fit neatly into the standard 8-K taxonomy (not earnings, M&A, impairment, litigation, or other defined categories). The magnitude ($275M) and regulatory significance warrant classification as material, but the event is best captured as "other_material" given its regulatory approval nature.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 7.01
QXO announced a $3.0 billion debt offering ($1.5B of 6.500% Senior Notes due 2031 and $1.5B of 6.875% Senior Notes due 2034) priced at par and expected to close June 17, 2026. While this is a material financing event affecting the registrant's capital structure and liquidity, it does not fit cleanly into the standard taxonomy categories (not a dilutive equity issuance, not M&A activity, not a restatement or covenant breach). The disclosure is material to investors assessing the company's financial position, particularly given the pending TopBuild acquisition referenced in the forward-looking statements.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-04
Item 8.01
American Tower terminated its Strategic Collocation Agreement with DISH effective June 2, 2026, and is pursuing litigation against DISH regarding SCA obligations. While the company states the termination is not expected to impact 2026 financial results (as DISH revenue was already fully reflected in churn as of January 1, 2026), the termination of a material commercial agreement and ongoing litigation represent a significant business event that would affect a reasonable investor's assessment of the company's customer relationships and revenue stability. This does not fit neatly into the more specific categories (not a restatement, impairment, covenant breach, or litigation settlement), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-04
Item 7.01
Alaska Silver Corp. disclosed commencement of a 2026 drill program at Illinois Creek targeting resource expansion and new discoveries. While this is operational/exploration activity rather than a discrete event category (earnings, M&A, executive change, etc.), the initiation of a material exploration program at a mining company's primary asset could affect investor assessment of near-term prospects and resource potential. The Item 7.01 disclosure format and Regulation FD language suggest the company deemed this newsworthy enough to disclose promptly, though the materiality is somewhat ambiguous without knowing the significance of Illinois Creek to the company's overall strategy.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-04
Item 2.03
USBC drew an additional $5.0 million under its Master Loan Agreement with Payward Interactive, bringing total borrowings to $15.0 million at 8.5% interest, secured by Bitcoin collateral with a 130% margin call threshold.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 8.01
USBC disclosed its multi-phase development and deployment strategy for a tokenized deposit product in collaboration with Vast Bank, with Phase 1 infrastructure and technical testing underway, $3.9 million in reimbursements incurred to date under a $10.5 million capped Affiliate Services Agreement, and anticipated significant future development costs.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 8.01
Wisconsin Electric Power Company entered into an underwriting agreement on June 1, 2026, to issue $800 million in aggregate principal amount of debentures ($400 million of 4.65% debentures due 2031 and $400 million of 5.10% debentures due 2036). While this is a material debt issuance that would affect a reasonable investor's assessment of the company's capital structure and financial position, it does not fit cleanly into the more specific event categories (e.g., it is not a dilutive equity issuance under Item 3.02, nor is it an M&A activity). The disclosure is material but is best classified as other_material given the taxonomy constraints.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 5.03
The company changed its legal name from "IAC Inc." to "People Incorporated" and its ticker symbol from "IAC" to "PPLI" effective June 4, 2026, pursuant to a Certificate of Amendment to its Restated Certificate of Incorporation. While this is a corporate name and ticker change disclosed under Item 5.03, it does not fit neatly into the more specific event categories (it is not a bylaw amendment for governance purposes, nor a fiscal year change despite the Item heading). The name and ticker change would materially affect investor identification and trading of the security, making it material to reasonable investors, but the event is best classified as other_material since no dedicated taxonomy category captures a corporate name/ticker change.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-04
Item 8.01
Quoin Pharmaceuticals announced that Japan's Ministry of Health, Labour and Welfare (MHLW) granted Orphan Drug Designation to QRX003 lotion for the treatment of Netherton Syndrome. This designation provides significant development incentives including prioritized consultation, reduced fees, tax benefits, priority review, and up to 10 years of market exclusivity, representing a material regulatory milestone for the company's pipeline.
View raw filing on EDGAR →
8-K
Other material
confidence 50%
filed 2026-06-04
Item 1.01
B&G Foods entered into a material definitive agreement and announced a $475 million private placement of senior notes to refinance existing debt, representing a material capital restructuring transaction.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 7.01
ArcBest is providing a detailed operational update on Q2 2026 performance through May, including year-over-year and sequential trends for both Asset-Based and Asset-Light segments, along with forward-looking guidance on operating income and operating ratio improvements. While this is disclosed under Item 7.01 (Regulation FD Disclosure) rather than a formal earnings release, the granular operational metrics, revenue trends, and specific Q2 guidance (e.g., Asset-Light operating income of $3–5 million) constitute material business information that would affect a reasonable investor's assessment of near-term performance and trends. The disclosure does not fit neatly into earnings_release (no full financial statements or formal press release format) but is clearly material forward-looking guidance on operational performance.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 7.01
Femasys announced a 1-for-20 reverse stock split effective June 5, 2026, with trading on a split-adjusted basis beginning June 8, 2026. While reverse stock splits are material corporate actions affecting share structure and investor holdings, this disclosure does not fit neatly into the specific event-type taxonomy (not an earnings release, executive change, M&A, impairment, covenant breach, or other enumerated categories). The reverse split is a material event that would affect a reasonable investor's assessment of share ownership and market capitalization, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 8.01
Southern Power Company entered into an underwriting agreement on June 1, 2026 to issue $600 million in senior notes due 2031. While this is a material debt issuance that would affect investor assessment of the company's capital structure and financial position, it does not fit cleanly into the more specific event categories (it is not M&A activity, a dilutive equity issuance, or a covenant breach). The disclosure is appropriately classified as other_material given its significance and the absence of a more precise taxonomy match.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-04
Item 7.01
X-Energy announced an early lock-up release date of September 1, 2026 for officers, directors, and substantial shareholders following the company's IPO, triggered by a blackout-period exception that signals when insider selling restrictions will lift.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 8.01
Fractyl Health announced positive one-year clinical trial results from the REVEAL-1 Cohort for its Revita procedure in obesity treatment, demonstrating 78% maintenance of GLP-1-induced weight loss with a favorable safety profile.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 8.01
Goodyear entered into an underwriting agreement on June 1, 2026 to issue $1.05 billion in 8.875% Senior Notes due 2032, with the offering expected to close on June 4, 2026. While this is a material debt issuance that would affect investor assessment of the company's capital structure and financial obligations, it does not fit cleanly into the more specific event categories (it is neither a dilutive equity issuance under Item 3.02, nor an M&A activity, nor a covenant breach). The disclosure is a straightforward debt offering registered under the Securities Act, disclosed under Item 8.01 (Other Events).
View raw filing on EDGAR →